Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shantel Angstadt

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|February 17, 2022
Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical ImplicationsShantel Angstadt, Qingfeng Zhu, Elizabeth M Jaffee, et al.
Biomaterials|August 28, 2016
Dental cell sheet biomimetic tooth bud modelNelson Monteiro, Elizabeth E Smith, Shantel Angstadt, et al.
Journal for Immunotherapy of Cancer|September 7, 2023
Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysisMadeline Dahut, Kristen Fousek, Lucas A Horn, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 5, 2024
Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer modelsLucas A Horn, Hanne Lind, Kristen Fousek, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|February 17, 2022
Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical ImplicationsShantel Angstadt, Qingfeng Zhu, Elizabeth M Jaffee, et al.
Biomaterials|August 28, 2016
Dental cell sheet biomimetic tooth bud modelNelson Monteiro, Elizabeth E Smith, Shantel Angstadt, et al.
Journal for Immunotherapy of Cancer|September 7, 2023
Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysisMadeline Dahut, Kristen Fousek, Lucas A Horn, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 5, 2024
Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer modelsLucas A Horn, Hanne Lind, Kristen Fousek, et al.
Pageof 1